Literature DB >> 17443328

Serum oxidative-antioxidative status in patients with ankylosing spondilitis.

Mehmet Karakoc1, Ozlem Altindag, Huseyin Keles, Neslihan Soran, Sahabettin Selek.   

Abstract

Ankylosing spondylitis (AS) is an inflammatory disorder with unknown etiology that mainly affects the axial skeleton as well as the peripheral joints and extra-articular structures. The aim of this study was to evaluate the total antioxidant status (TAS), total oxidative status (TOS) and oxidative stress index (OSI) in patients with ankylosing spondylitis (AS). Fifty AS patients with a mean Bath AS Activity Index (BASDAI) 4.6 (range 4-9.3) and 26 healthy controls were included in the study. Plasma TAS, TOS levels were determined by using novel automated methods. The OSI was calculated. Plasma TOS level and OSI values were significantly higher, and plasma TAS level was lower in patients than in healthy controls (15.8 +/- 4. 9 vs. 4.3 +/- 2.8, 12.8 +/- 3. 9 vs. 9.6 +/- 5.5, 1.2 +/- 0.03 vs. 1.8 +/- 0.2, respectively, P < 0.001 for all). There was no significant correlation between oxidant/antioxidant parameters and disease activity. The results of this study indicated that increased oxidant and decreased antioxidant capacity may be associated with the pathogenesis of AS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17443328     DOI: 10.1007/s00296-007-0352-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  21 in total

1.  A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation.

Authors:  Ozcan Erel
Journal:  Clin Biochem       Date:  2004-04       Impact factor: 3.281

2.  Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis.

Authors:  Sezgin Sarban; Abdurrahim Kocyigit; Mithat Yazar; Ugur E Isikan
Journal:  Clin Biochem       Date:  2005-09-16       Impact factor: 3.281

3.  A new automated colorimetric method for measuring total oxidant status.

Authors:  Ozcan Erel
Journal:  Clin Biochem       Date:  2005-10-07       Impact factor: 3.281

4.  Lipid peroxidation and homocysteine levels in Behçet's disease.

Authors:  A Görkem Mungan; Murat Can; Serefden Açikgöz; Emel Eştürk; Cevdet Altinyazar
Journal:  Clin Chem Lab Med       Date:  2006       Impact factor: 3.694

5.  Hypoxic-reperfusion injury in the inflamed human joint.

Authors:  D R Blake; P Merry; J Unsworth; B L Kidd; J M Outhwaite; R Ballard; C J Morris; L Gray; J Lunec
Journal:  Lancet       Date:  1989-02-11       Impact factor: 79.321

6.  Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?

Authors:  A Calin; J P Nakache; A Gueguen; H Zeidler; H Mielants; M Dougados
Journal:  Rheumatology (Oxford)       Date:  1999-09       Impact factor: 7.580

7.  Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis.

Authors:  Salih Ozgocmen; Sadik Sogut; Ozge Ardicoglu; Ersin Fadillioglu; Irfan Pekkutucu; Omer Akyol
Journal:  Rheumatol Int       Date:  2003-06-17       Impact factor: 2.631

8.  Elevated serum nitrate concentrations in active spondyloarthropathies.

Authors:  D O Stichtenoth; J Wollenhaupt; D Andersone; H Zeidler; J C Frölich
Journal:  Br J Rheumatol       Date:  1995-07

9.  Free-radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis.

Authors:  J Lunec; S P Halloran; A G White; T L Dormandy
Journal:  J Rheumatol       Date:  1981 Mar-Apr       Impact factor: 4.666

Review 10.  Oxidation in rheumatoid arthritis.

Authors:  Carol A Hitchon; Hani S El-Gabalawy
Journal:  Arthritis Res Ther       Date:  2004-10-13       Impact factor: 5.156

View more
  24 in total

1.  Serum melatonin level in ankylosing spondylitis: is it increased in active disease?

Authors:  Mohammad Kamal Senna; Shereen Mohamed Olama; Mohammad El-Arman
Journal:  Rheumatol Int       Date:  2011-11-06       Impact factor: 2.631

2.  Serum prolidase activity and oxidative-antioxidative status in patients with developmental dysplasia of the hip and its relationship with radiographic severity.

Authors:  Mehmet Akif Altay; Cemil Ertürk; Ali Levent; Baki Volkan Çetin; Nurten Aksoy
Journal:  Redox Rep       Date:  2016-06-20       Impact factor: 4.412

3.  Oxidative stress and related factors in patients with ankylosing spondylitis.

Authors:  Dilek Solmaz; Didem Kozacı; İsmail Sarı; Ali Taylan; Fatoş Önen; Nurullah Akkoç; Servet Akar
Journal:  Eur J Rheumatol       Date:  2016-01-29

4.  Evaluation of paraoxonase and arylesterase activities in Egyptian patients with ankylosing spondylitis.

Authors:  Shereem Mohamed Olama; Mohammed Mohamed Elarman
Journal:  Rheumatol Int       Date:  2012-12-14       Impact factor: 2.631

5.  The effect of anti-TNF agent on oxidation status in patients with ankylosing spondylitis.

Authors:  Murat Karkucak; Erhan Capkin; Ahmet Alver; Ayse Akyuz; Abdulkadir Kiris; Emel Ak; Murat Topbas; Mehmet Tosun
Journal:  Clin Rheumatol       Date:  2009-12-11       Impact factor: 2.980

6.  Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients.

Authors:  Fazile Hatipoglu Erdem; Saliha Karatay; Kadir Yildirim; Ahmet Kiziltunc
Journal:  Clinics (Sao Paulo)       Date:  2010-02       Impact factor: 2.365

7.  Protective effect of naringin against ankylosing spondylitis via ossification, inflammation and oxidative stress in mice.

Authors:  Kang Liu; Lianguo Wu; Xiaolin Shi; Fengqing Wu
Journal:  Exp Ther Med       Date:  2016-05-31       Impact factor: 2.447

8.  Thiol/disulfide homeostasis in patients with ankylosing spondylitis.

Authors:  Atalay Dogru; Ayse Balkarli; Gozde Yildirim Cetin; Salim Neselioglu; Ozcan Erel; Sevket Ercan Tunc; Mehmet Sahin
Journal:  Bosn J Basic Med Sci       Date:  2016-05-16       Impact factor: 3.363

9.  Attenuation of adjuvant-induced arthritis by dietary sesamol via modulation of inflammatory mediators, extracellular matrix degrading enzymes and antioxidant status.

Authors:  Mahadevappa Hemshekhar; Ram Mohan Thushara; Sadashivaiah Jnaneshwari; Sannaningaiah Devaraja; Kempaiah Kemparaju; Kesturu Subbaiah Girish
Journal:  Eur J Nutr       Date:  2012-12-27       Impact factor: 5.614

10.  Total oxidative stress and antioxidant status in patients with carpal tunnel syndrome.

Authors:  Ahmet Demirkol; Murat Uludag; Neslihan Soran; Nurten Aksoy; Kerem Gun; Serap Incebıyık; Ismahan Gurgen; Mehmet Vural; Yasşar Altun; Fatma Nur Kesiktas
Journal:  Redox Rep       Date:  2012-10-15       Impact factor: 4.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.